Vitamin D inhibits the occurrence of experimental cerebral malaria in mice by suppressing the host inflammatory response

Journal of Immunology

Volumn 193, Issue 3, 2014, Pages 1314-1323

  He, Xiyue ^a   Yan, Juan ^a   Zhu, Xiaotong ^a,b   Wang, Qinghui ^a   Pang, Wei ^a   Qi, Zanmei ^a   Wang, Meilian ^a   Luo, Enjie ^a   Parker, Daniel M ^b   Cantorna, Margherita T ^b   Cui, Liwang ^b   Cao, Yaming ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD36 ANTIGEN; COLECALCIFEROL; CXCL9 CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 10; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TUMOR NECROSIS FACTOR; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN MALARIA; BRAIN TISSUE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL EXPANSION; CELL MATURATION; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG EFFECT; EXPERIMENTAL CEREBRAL MALARIA; EXPERIMENTAL INFECTION; FEMALE; IMMUNE RESPONSE; INFECTION PREVENTION; INFLAMMATION; MOUSE; NONHUMAN; PLASMODIUM BERGHEI INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SPLEEN CELL; TH1 CELL; UPREGULATION;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DENDRITIC CELLS; DOWN-REGULATION; FEMALE; GROWTH INHIBITORS; HOST-PARASITE INTERACTIONS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION; INTERFERON-GAMMA; MALARIA, CEREBRAL; MICE; MICE, INBRED C57BL; PLASMODIUM BERGHEI; PRIMARY CELL CULTURE; RANDOM ALLOCATION; T-LYMPHOCYTES, REGULATORY; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION; VITAMIN D;

EID: 84906094397     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1400089     Document Type: Article

References (66)

1. van der Heyde, H. C., J. Nolan, V. Combes, I. Gramaglia, and G. E. Grau. 2006. A unified hypothesis for the genesis of cerebral malaria: sequestration, inflammation and hemostasis leading to microcirculatory dysfunction. Trends Parasitol. 22: 503-508.
2. Miller, L. H., D. I. Baruch, K. Marsh, and O. K. Doumbo. 2002. The pathogenic basis of malaria. Nature 415: 673-679.
3. de Souza, J. B., and E. M. Riley. 2002. Cerebral malaria: the contribution of studies in animal models to our understanding of immunopathogenesis. Microbes Infect. 4: 291-300.
4. Schofield, L., and G. E. Grau. 2005. Immunological processes in malaria pathogenesis. Nat. Rev. Immunol. 5: 722-735.
5. Mitchell, A. J., A. M. Hansen, L. Hee, H. J. Ball, S. M. Potter, J. C. Walker, and N. H. Hunt. 2005. Early cytokine production is associated with protection from murine cerebral malaria. Infect. Immun. 73: 5645-5653.
6. Riley, E. M., S. Wahl, D. J. Perkins, and L. Schofield. 2006. Regulating immunity to malaria. Parasite Immunol. 28: 35-49.
7. Grau, G. E., G. Bieler, P. Pointaire, S. De Kossodo, F. Tacchini-Cotier, P. Vassalli, P. F. Piguet, and P. H. Lambert. 1990. Significance of cytokine production and adhesion molecules in malarial immunopathology. Immunol. Lett. 25: 189-194.
8. Grau, G. E., K. Frei, P. F. Piguet, A. Fontana, H. Heremans, A. Billiau, P. Vassalli, and P. H. Lambert. 1990. Interleukin 6 production in experimental cerebral malaria: modulation by anticytokine antibodies and possible role in hypergammaglobulinemia. J. Exp. Med. 172: 1505-1508.
9. Mills, K. H. 2004. Regulatory T cells: friend or foe in immunity to infection? Nat. Rev. Immunol. 4: 841-855.
10. Belkaid, Y., C. M. Sun, and N. Bouladoux. 2006. Parasites and immunoregulatory T cells. Curr. Opin. Immunol. 18: 406-412.
11. Suvas, S., and B. T. Rouse. 2006. Treg control of antimicrobial T cell responses. Curr. Opin. Immunol. 18: 344-348.
12. Demengeot, J., S. Zelenay, M. F. Moraes-Fontes, I. Caramalho, and A. Coutinho. 2006. Regulatory T cells in microbial infection. Springer Semin. Immunopathol. 28: 41-50.
13. Nie, C. Q., N. J. Bernard, L. Schofield, and D. S. Hansen. 2007. CD4+CD25+ regulatory T cells suppress CD4+ T-cell function and inhibit the development of Plasmodium berghei-specific TH1 responses involved in cerebral malaria pathogenesis. Infect. Immun. 75: 2275-2282.
14. Haque, A., S. E. Best, F. H. Amante, S. Mustafah, L. Desbarrieres, F. de Labastida, T. Sparwasser, G. R. Hill, and C. R. Engwerda. 2010. CD4+ natural regulatory T cells prevent experimental cerebral malaria via CTLA-4 when expanded in vivo. PLoS Pathog. 6: e1001221.
15. Hewison, M. 2012. Vitamin D and the immune system: new perspectives on an old theme. Rheum. Dis. Clin. North Am. 38: 125-139.
16. Xu, H., A. Soruri, R. K. Gieseler, and J. H. Peters. 1993. 1,25-Dihydroxyvitamin D3 exerts opposing effects to IL-4 on MHC class-II antigen expression, accessory activity, and phagocytosis of human monocytes. Scand. J. Immunol. 38: 535-540.
17. Berer, A., J. Stöckl, O. Majdic, T. Wagner, M. Kollars, K. Lechner, K. Geissler, and L. Oehler. 2000. 1,25-Dihydroxyvitamin D(3) inhibits dendritic cell differentiation and maturation in vitro. Exp. Hematol. 28: 575-583.
18. de Sá, M. S., J. F. Costa, A. U. Krettli, M. G. Zalis, G. L. Maia, I. M. Sette, Cde. A. Camara, J. M. Filho, A. M. Giulietti-Harley, R. Ribeiro Dos Santos, and M. B. Soares. 2009. Antimalarial activity of betulinic acid and derivatives in vitro against Plasmodium falciparum and in vivo in P. berghei-infected mice. Parasitol. Res. 105: 275-279.
19. Jeffery, L. E., F. Burke, M. Mura, Y. Zheng, O. S. Qureshi, M. Hewison, L. S. Walker, D. A. Lammas, K. Raza, and D. M. Sansom. 2009. 1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J. Immunol. 183: 5458-5467.
20. Zhu, Y., B. D. Mahon, M. Froicu, and M. T. Cantorna. 2005. Calcium and 1a,25-dihydroxyvitamin D3 target the TNF- A pathway to suppress experimental inflammatory bowel disease. Eur. J. Immunol. 35: 217-224.
21. Bruce, D., J. H. Ooi, S. Yu, and M. T. Cantorna. 2010. Vitamin D and host resistance to infection? Putting the cart in front of the horse. Exp. Biol. Med. (Maywood) 235: 921-927.
22. Newens, K., S. Filteau, and A. Tomkins. 2006. Plasma 25-hydroxyvitamin D does not vary over the course of a malarial infection. Trans. R. Soc. Trop. Med. Hyg. 100: 41-44.
23. Sudfeld, C. R., E. L. Giovannucci, S. Isanaka, S. Aboud, F. M. Mugusi, M. Wang, G. Chalamilla, and W. W. Fawzi. 2013. Vitamin D status and incidence of pulmonary tuberculosis, opportunistic infections, and wasting among HIV-infected Tanzanian adults initiating antiretroviral therapy. J. Infect. Dis. 207: 378-385.
24. Sergacheva, I., T. L. Sokhanenkova, F. F. Soprunov, and A. A. Lur'e. 1986. Effect of vitamin D and E on the development of Plasmodium berghei infection in mice [in Russian]. Med. Parasitol. 15-18.
25. Waisberg, M., B. K. Vickers, S. B. Yager, C. K. Lin, and S. K. Pierce. 2012. Testing in mice the hypothesis that melanin is protective in malaria infections. PLoS One 7: e29493.
26. Yamakuchi, M., N. C. Kirkiles-Smith, M. Ferlito, S. J. Cameron, C. Bao, K. Fox-Talbot, B. A. Wasowska, W. M. Baldwin, III, J. S. Pober, and C. J. Lowenstein. 2007. Antibody to human leukocyte antigen triggers endothelial exocytosis. Proc. Natl. Acad. Sci. USA 104: 1301-1306.
27. Gramaglia, I., P. Sobolewski, D. Meays, R. Contreras, J. P. Nolan, J. A. Frangos, M. Intaglietta, and H. C. van der Heyde. 2006. Low nitric oxide bioavailability contributes to the genesis of experimental cerebral malaria. Nat. Med. 12: 1417-1422.
28. Su, Z., and M. M. Stevenson. 2002. IL-12 is required for antibody-mediated protective immunity against blood-stage Plasmodium chabaudi AS malaria infection in mice. J. Immunol. 168: 1348-1355.
29. Zheng, W., Q. H. Wang, H. Feng, J. Liu, H. R. Meng, and Y. M. Cao. 2009. CD4+ CD25+Foxp3+ regulatory T cells prevent the development of Th1 immune response by inhibition of dendritic cell function during the early stage of Plasmodium yoelii infection in susceptible BALB/c mice. Folia Parasitol. 56: 242-250.
30. Morrell, C. N., K. Srivastava, A. Swaim, M. T. Lee, J. Chen, C. Nagineni, J. J. Hooks, and B. Detrick. 2011. Beta interferon suppresses the development of experimental cerebral malaria. Infect. Immun. 79: 1750-1758.
31. Rénia, L., S. W. Howland, C. Claser, A. Charlotte Gruner, R. Suwanarusk, T. Hui Teo, B. Russell, and L. F. Ng. 2012. Cerebral malaria: mysteries at the bloodbrain barrier. Virulence 3: 193-201.
32. Medana, I. M., and G. D. Turner. 2006. Human cerebral malaria and the bloodbrain barrier. Int. J. Parasitol. 36: 555-568.
33. Favre, N., C. Da Laperousaz, B. Ryffel, N. A. Weiss, B. A. Imhof, W. Rudin, R. Lucas, and P. F. Piguet. 1999. Role of ICAM-1 (CD54) in the development of murine cerebral malaria. Microbes Infect. 1: 961-968.
34. Bauer, P. R., H. C. Van Der Heyde, G. Sun, R. D. Specian, and D. N. Granger. 2002. Regulation of endothelial cell adhesion molecule expression in an experimental model of cerebral malaria. Microcirculation 9: 463-470.
35. Belnoue, E., S. M. Potter, D. S. Rosa, M. Mauduit, A. C. Grüner, M. Kayibanda, A. J. Mitchell, N. H. Hunt, and L. Rénia. 2008. Control of pathogenic CD8+ T cell migration to the brain by IFN-g during experimental cerebral malaria. Parasite Immunol. 30: 544-553.
36. Campanella, G. S., A. M. Tager, J. K. El Khoury, S. Y. Thomas, T. A. Abrazinski, L. A. Manice, R. A. Colvin, and A. D. Luster. 2008. Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria. Proc. Natl. Acad. Sci. USA 105: 4814-4819.
37. Van den Steen, P. E., K. Deroost, I. Van Aelst, N. Geurts, E. Martens, S. Struyf, C. Q. Nie, D. S. Hansen, P. Matthys, J. Van Damme, and G. Opdenakker. 2008. CXCR3 determines strain susceptibility to murine cerebral malaria by mediating T lymphocyte migration toward IFN-g-induced chemokines. Eur. J. Immunol. 38: 1082-1095.
38. Engwerda, C., E. Belnoue, A. C. Grüner, and L. Rénia. 2005. Experimental models of cerebral malaria. Curr. Top. Microbiol. Immunol. 297: 103-143.
39. Amani, V., A. M. Vigário, E. Belnoue, M. Marussig, L. Fonseca, D. Mazier, and L. Rénia. 2000. Involvement of IFN-g receptor-medicated signaling in pathology and anti-malarial immunity induced by Plasmodium berghei infection. Eur. J. Immunol. 30: 1646-1655.
40. Wilson, N. S., and J. A. Villadangos. 2005. Regulation of antigen presentation and cross-presentation in the dendritic cell network: facts, hypothesis, and immunological implications. Adv. Immunol. 86: 241-305.
41. Gebreegziabher, T., and B. J. Stoecker. 2013. Vitamin D insufficiency in a sunshine-sufficient area: southern Ethiopia. Food Nutr. Bull. 34: 429-433.
42. Nurbazlin, M., W. S. Chee, P. Rokiah, A. T. Tan, Y. Y. Chew, A. R. Nusaibah, and S. P. Chan. 2013. Effects of sun exposure on 25(OH) vitamin D concentration in urban and rural women in Malaysia. Asia Pac. J. Clin. Nutr. 22: 391-399.
43. Djennane, M., S. Lebbah, C. Roux, H. Djoudi, E. Cavalier, and J. C. Souberbielle. 2014. Vitamin D status of schoolchildren in Northern Algeria, seasonal variations and determinants of vitamin D deficiency. Osteoporos. Int. 25: 1493-1502.
44. Carter, S. L., M. Müller, P. M. Manders, and I. L. Campbell. 2007. Induction of the genes for Cxcl9 and Cxcl10 is dependent on IFN-g but shows differential cellular expression in experimental autoimmune encephalomyelitis and by astrocytes and microglia in vitro. Glia 55: 1728-1739.
45. Belnoue, E., M. Kayibanda, A. M. Vigario, J. C. Deschemin, N. van Rooijen, M. Viguier, G. Snounou, and L. Rénia. 2002. On the pathogenic role of brainsequestered abCD8+ T cells in experimental cerebral malaria. J. Immunol. 169: 6369-6375.
46. Rigby, W. F., S. Denome, and M. W. Fanger. 1987. Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3: specific inhibition at the level of messenger RNA. J. Clin. Invest. 79: 1659-1664.
47. Boonstra, A., F. J. Barrat, C. Crain, V. L. Heath, H. F. Savelkoul, and A. O'Garra. 2001. 1a,25-Dihydroxyvitamin d3 has a direct effect on naive CD4+ T cells to enhance the development of Th2 cells. J. Immunol. 167: 4974-4980.
48. Hakim, I., and Z. Bar-Shavit. 2003. Modulation of TNF- A expression in bone marrow macrophages: involvement of vitamin D response element. J. Cell. Biochem. 88: 986-998.
49. Baeke, F., T. Takiishi, H. Korf, C. Gysemans, and C. Mathieu. 2010. Vitamin D: modulator of the immune system. Curr. Opin. Pharmacol. 10: 482-496.
50. Reichel, H., H. P. Koeffler, A. Tobler, and A. W. Norman. 1987. 1a,25-Dihydroxyvitamin D3 inhibits g-interferon synthesis by normal human peripheral blood lymphocytes. Proc. Natl. Acad. Sci. USA 84: 3385-3389.
51. Voisine, C., B. Mastelic, A. M. Sponaas, and J. Langhorne. 2010. Classical CD11c+ dendritic cells, not plasmacytoid dendritic cells, induce T cell responses to Plasmodium chabaudi malaria. Int. J. Parasitol. 40: 711-719.
52. Chattopadhyay, S., N. G. Chakraborty, and B. Mukherji. 2005. Regulatory T cells and tumor immunity. Cancer Immunol. Immunother. 54: 1153-1161.
53. Takeda, M., T. Yamashita, N. Sasaki, K. Nakajima, T. Kita, M. Shinohara, T. Ishida, and K. Hirata. 2010. Oral administration of an active form of vitamin D3 (calcitriol) decreases atherosclerosis in mice by inducing regulatory T cells and immature dendritic cells with tolerogenic functions. Arterioscler. Thromb. Vasc. Biol. 30: 2495-2503.
54. Enioutina, E. Y., D. Bareyan, and R. A. Daynes. 2009. TLR-induced local metabolism of vitamin D3 plays an important role in the diversification of adaptive immune responses. J. Immunol. 182: 4296-4305.
55. Gleisner, M. A., M. Rosemblatt, J. A. Fierro, and M. R. Bono. 2011. Delivery of alloantigens via apoptotic cells generates dendritic cells wit apoptotic cells generates dendritic cells with an immature tolerogenic phenotype. Transplant. Proc. 43: 2325-2333.
56. Imazeki, I., J. Matsuzaki, K. Tsuji, and T. Nishimura. 2006. Immunomodulating effect of vitamin D3 derivatives on type-1 cellular immunity. Biomed. Res. 27: 1-9.
57. Berretta, F., J. St-Pierre, C. A. Piccirillo, and M. M. Stevenson. 2011. IL-2 contributes to maintaining a balance between CD4+Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of blood-stage malaria infection. J. Immunol. 186: 4862-4871.
58. Gonçalves, R. M., K. C. Salmazi, B. A. Santos, M. S. Bastos, S. C. Rocha, S. B. Boscardin, A. M. Silber, E. G. Kallás, M. U. Ferreira, and K. K. Scopel. 2010. CD4+CD25+Foxp3+ regulatory T cells, dendritic cells, and circulating cytokines in uncomplicated malaria: do different parasite species elicit similar host responses? Infect. Immun. 78: 4763-4772.
59. Gorman, S., L. A. Kuritzky, M. A. Judge, K. M. Dixon, J. P. McGlade, R. S. Mason, J. J. Finlay-Jones, and P. H. Hart. 2007. Topically applied 1,25-dihydroxyvitamin D3 enhances the suppressive activity of CD4+CD25+ cells in the draining lymph nodes. J. Immunol. 179: 6273-6283.
60. Urry, Z., E. Xystrakis, D. F. Richards, J. McDonald, Z. Sattar, D. J. Cousins, C. J. Corrigan, E. Hickman, Z. Brown, and C. M. Hawrylowicz. 2009. Ligation of TLR9 induced on human IL-10-secreting Tregs by 1a,25- dihydroxyvitamin D3 abrogates regulatory function. J. Clin. Invest. 119: 387-398.
61. Bikle, D. 2009. Nonclassic actions of vitamin D. J. Clin. Endocrinol. Metab. 94: 26-34.
62. Vigário, A. M., O. Gorgette, H. C. Dujardin, T. Cruz, P. A. Cazenave, A. Six, A. Bandeira, and S. Pied. 2007. Regulatory CD4+CD25+Foxp3+ T cells expand during experimental Plasmodium infection but do not prevent cerebral malaria. Int. J. Parasitol. 37: 963-973.
63. Chambers, E. S., and C. M. Hawrylowicz. 2011. The impact of vitamin D on regulatory T cells. Curr. Allergy Asthma Rep. 11: 29-36.
64. Roelen, D. L., D. E. van den Boogaardt, P. P. van Miert, K. Koekkoek, R. Offringa, and F. H. Claas. 2008. Differentially modulated dendritic cells induce regulatory T cells with different characteristics. Transpl. Immunol. 19: 220-228.
65. Unger, W. W., S. Laban, F. S. Kleijwegt, A. R. van der Slik, and B. O. Roep. 2009. Induction of Treg by monocyte-derived DC modulated by vitamin D3 or dexamethasone: differential role for PD-L1. Eur. J. Immunol. 39: 3147-3159.
66. Baeke, F., H. Korf, L. Overbergh, A. Verstuyf, L. Thorrez, L. Van Lommel, M. Waer, F. Schuit, C. Gysemans, and C. Mathieu. 2011. The vitamin D analog, TX527, promotes a human CD4+CD25highCD127low regulatory T cell profile and induces a migratory signature specific for homing to sites of inflammation. J. Immunol. 186: 132-142.